DOLK-CDG (CDG-Im)

From WikiMD's Medical Encyclopedia

Revision as of 13:12, 2 December 2020 by Deepika vegiraju (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Other Names: Congenital disorder of glycosylation, type Im ; CDG Im; CDGIm; DOLICHOL KINASE DEFICIENCY; DK1 DEFICIENCY; Carbohydrate deficient glycoprotein syndrome type Im; Hypotonia and ichthyosis due to dolichol phosphate deficiency; CDG syndrome type Im; CDG-Im; CDG1M; Congenital disorder of glycosylation type 1m; Congenital disorder of glycosylation type Im; DK1-CDG

DOLK-congenital disorder of glycosylation (DOLK-CDG, formerly known as congenital disorder of glycosylation type Im) is an inherited condition that often affects the heart but can also involve other body systems. The pattern and severity of this disorder's signs and symptoms vary among affected individuals.

Epidemiology[edit]

DOLK-CDG is likely a rare condition; at least 18 cases have been reported in the scientific literature.

Cause[edit]

DOLK-CDG is caused by mutations in the DOLK gene. This gene provides instructions for making the enzyme dolichol kinase, which facilitates the final step of the production of a compound called dolichol phosphate. This compound is critical for a process called glycosylation, which attaches groups of sugar molecules (oligosaccharides) to proteins. Glycosylation changes proteins in ways that are important for their functions. During glycosylation, sugars are added to dolichol phosphate in order to build the oligosaccharide chain. Once the chain is formed, dolichol phosphate transports the oligosaccharide to the protein that needs to be glycosylated and attaches it to a specific site on the protein.

Mutations in the DOLK gene lead to the production of abnormal dolichol kinase with reduced or absent activity. Without properly functioning dolichol kinase, dolichol phosphate is not produced and glycosylation cannot proceed normally. In particular, a protein known to stabilize heart muscle fibers, called alpha-dystroglycan, has been shown to have reduced glycosylation in people with DOLK-CDG. Impaired glycosylation of alpha-dystroglycan disrupts its normal function, which damages heart muscle fibers as they repeatedly contract and relax. Over time, the fibers weaken and break down, leading to dilated cardiomyopathy. The other signs and symptoms of DOLK-CDG are likely due to the abnormal glycosylation of additional proteins in other organs and tissues.

Inheritance[edit]

Autosomal recessive inheritance, a 25% chance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Signs and symptoms[edit]

Individuals with DOLK-CDG typically develop signs and symptoms of the condition during infancy or early childhood. Nearly all individuals with DOLK-CDG develop a weakened and enlarged heart (dilated cardiomyopathy). Other frequent signs and symptoms include recurrent seizures; developmental delay; poor muscle tone (hypotonia); and dry, scaly skin (ichthyosis).

Less commonly, affected individuals can have distinctive facial features, kidney disease, hormonal abnormalities, or eye problems. Individuals with DOLK-CDG typically do not survive into adulthood, often because of complications related to dilated cardiomyopathy, and some do not survive past infancy.

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms

30%-79% of people have these symptoms

  • Abnormality of coagulation
  • Cerebral cortical atrophy(Decrease in size of the outer layer of the brain due to loss of brain cells)
  • Hepatomegaly(Enlarged liver)
  • Myalgia(Muscle ache)
  • Splenomegaly(Increased spleen size)

5%-29% of people have these symptoms

  • Adactyly
  • Congenital hepatic fibrosis(Excessive buildup of connective tissue and scarring of liver at birth)
  • Elevated hepatic transaminase(High liver enzymes)
  • Muscular hypotonia(Low or weak muscle tone)

Diagnosis[edit]

Treatment[edit]

NIH genetic and rare disease info[edit]

DOLK-CDG (CDG-Im) is a rare disease.


This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.